for Veterans and the Public
Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations
For the full PDF version, click here
This revision (July 28, 2015) incorporates preferred regimens for chronic hepatitis C virus (HCV) genotypes 1 and 4, and extension to 16 weeks of treatment for HCV genotype 2 with cirrhosis. Additional revisions include updates on principles of patient identification, evaluation, and treatment; laboratory monitoring; drug use in renal insufficiency; and drug-drug interactions to provide clinicians with guidance on the concomitant use of HCV drugs and other drugs including HIV antiretroviral agents (Appendix, Tables 4 and 5). The Panel continues to recommend that HIV/HCV-coinfected patients receive the same HCV antiviral regimen as HCV-monoinfected patients.